ATC code G02: Difference between revisions
Jump to navigation
Jump to search
imported>Whywhenwhohow add 2023 entries live on https://www.whocc.no/atc_ddd_index/ |
imported>Whywhenwhohow anchors, 2026 update |
||
| Line 1: | Line 1: | ||
{{ATC codes lead|G|02|Other gynecologicals|vet=add}} | {{ATC codes lead|G|02|Other gynecologicals|vet=add}} | ||
== | ==<span class="anchor" id="G02A"></span>G02A Uterotonics== | ||
=== | ===<span class="anchor" id="G02AB"></span>G02AB Ergot alkaloids=== | ||
:G02AB01 [[Methylergometrine]] | :G02AB01 [[Methylergometrine]] | ||
:G02AB02 [[Ergot alkaloid]]s | :G02AB02 [[Ergot alkaloid]]s | ||
| Line 9: | Line 9: | ||
:QG02AB53 Ergometrine, combinations | :QG02AB53 Ergometrine, combinations | ||
=== | ===<span class="anchor" id="G02AC"></span>G02AC Ergot alkaloids and oxytocin including analogues, in combination=== | ||
:G02AC01 [[Methylergometrine]] and [[oxytocin]] | :G02AC01 [[Methylergometrine]] and [[oxytocin]] | ||
:QG02AC90 Ergometrine and oxytocin | :QG02AC90 Ergometrine and oxytocin | ||
=== | ===<span class="anchor" id="G02AD"></span>G02AD Prostaglandins=== | ||
:G02AD01 [[Dinoprost]] | :G02AD01 [[Dinoprost]] | ||
:G02AD02 [[Dinoprostone]] | :G02AD02 [[Dinoprostone]] | ||
| Line 27: | Line 27: | ||
:QG02AD95 [[Etiproston]] | :QG02AD95 [[Etiproston]] | ||
=== | ===<span class="anchor" id="G02AX"></span>G02AX Other uterotonics=== | ||
== | ==<span class="anchor" id="G02B"></span>G02B Contraceptives for topical use== | ||
=== | ===<span class="anchor" id="G02BA"></span>G02BA Intrauterine contraceptives=== | ||
:G02BA01 Plastic [[Intrauterine device|IUD]] | :G02BA01 Plastic [[Intrauterine device|IUD]] | ||
:G02BA02 [[Intrauterine device#Inert and copper-based devices|Plastic IUD with copper]] | :G02BA02 [[Intrauterine device#Inert and copper-based devices|Plastic IUD with copper]] | ||
:G02BA03 [[IntraUterine System|Plastic IUD with progestogen]] | :G02BA03 [[IntraUterine System|Plastic IUD with progestogen]] | ||
=== | ===<span class="anchor" id="G02BB"></span>G02BB Intravaginal contraceptives=== | ||
:G02BB01 [[Vaginal ring]] with [[progestogen]] and [[estrogen]] | :G02BB01 [[Vaginal ring]] with [[progestogen]] and [[estrogen]] | ||
:G02BB02 Vaginal ring with progestogen | :G02BB02 Vaginal ring with progestogen | ||
== | ==<span class="anchor" id="G02C"></span>G02C Other gynecologicals== | ||
=== | ===<span class="anchor" id="G02CA"></span>G02CA Sympathomimetics, labour repressants=== | ||
:G02CA01 [[Ritodrine]] | :G02CA01 [[Ritodrine]] | ||
:G02CA02 [[Buphenine]] | :G02CA02 [[Buphenine]] | ||
| Line 49: | Line 49: | ||
:QG02CA91 [[Clenbuterol]] | :QG02CA91 [[Clenbuterol]] | ||
=== | ===<span class="anchor" id="G02CB"></span>G02CB Prolactin inhibitors=== | ||
:G02CB01 [[Bromocriptine]] | :G02CB01 [[Bromocriptine]] | ||
:G02CB02 [[Lisuride]] | :G02CB02 [[Lisuride]] | ||
| Line 57: | Line 57: | ||
:G02CB06 [[Terguride]] | :G02CB06 [[Terguride]] | ||
=== | ===<span class="anchor" id="G02CC"></span>G02CC Anti-inflammatory products for vaginal administration=== | ||
:G02CC01 [[Ibuprofen]] | :G02CC01 [[Ibuprofen]] | ||
:G02CC02 [[Naproxen]] | :G02CC02 [[Naproxen]] | ||
| Line 63: | Line 63: | ||
:G02CC04 [[Flunoxaprofen]] | :G02CC04 [[Flunoxaprofen]] | ||
=== | ===<span class="anchor" id="G02CX"></span>G02CX Other gynecologicals=== | ||
:G02CX01 [[Atosiban]] | :G02CX01 [[Atosiban]] | ||
:G02CX02 [[Flibanserin]] | :G02CX02 [[Flibanserin]] | ||
| Line 70: | Line 70: | ||
:G02CX05 [[Bremelanotide]] | :G02CX05 [[Bremelanotide]] | ||
:G02CX06 [[Fezolinetant]] | :G02CX06 [[Fezolinetant]] | ||
:G02CX07 [[Elinzanetant]] | |||
:QG02CX90 [[Denaverine]] | :QG02CX90 [[Denaverine]] | ||
:QG02CX91 [[Lotrifen]] | :QG02CX91 [[Lotrifen]] | ||
Latest revision as of 00:31, 24 December 2025
G02A Uterotonics
G02AB Ergot alkaloids
- G02AB01 Methylergometrine
- G02AB02 Ergot alkaloids
- G02AB03 Ergometrine
- QG02AB53 Ergometrine, combinations
G02AC Ergot alkaloids and oxytocin including analogues, in combination
- G02AC01 Methylergometrine and oxytocin
- QG02AC90 Ergometrine and oxytocin
G02AD Prostaglandins
- G02AD01 Dinoprost
- G02AD02 Dinoprostone
- G02AD03 Gemeprost
- G02AD04 Carboprost
- G02AD05 Sulprostone
- G02AD06 Misoprostol
- QG02AD90 Cloprostenol
- QG02AD91 Luprostiol
- QG02AD92 Fenprostalene
- QG02AD93 Tiaprost
- QG02AD94 Alfaprostol
- QG02AD95 Etiproston
G02AX Other uterotonics
G02B Contraceptives for topical use
G02BA Intrauterine contraceptives
- G02BA01 Plastic IUD
- G02BA02 Plastic IUD with copper
- G02BA03 Plastic IUD with progestogen
G02BB Intravaginal contraceptives
- G02BB01 Vaginal ring with progestogen and estrogen
- G02BB02 Vaginal ring with progestogen
G02C Other gynecologicals
G02CA Sympathomimetics, labour repressants
- G02CA01 Ritodrine
- G02CA02 Buphenine
- G02CA03 Fenoterol
- QG02CA90 Vetrabutin
- QG02CA91 Clenbuterol
G02CB Prolactin inhibitors
- G02CB01 Bromocriptine
- G02CB02 Lisuride
- G02CB03 Cabergoline
- G02CB04 Quinagolide
- G02CB05 Metergoline
- G02CB06 Terguride
G02CC Anti-inflammatory products for vaginal administration
- G02CC01 Ibuprofen
- G02CC02 Naproxen
- G02CC03 Benzydamine
- G02CC04 Flunoxaprofen
G02CX Other gynecologicals
- G02CX01 Atosiban
- G02CX02 Flibanserin
- G02CX03 Agni casti fructus
- G02CX04 Cimicifugae rhizoma
- G02CX05 Bremelanotide
- G02CX06 Fezolinetant
- G02CX07 Elinzanetant
- QG02CX90 Denaverine
- QG02CX91 Lotrifen
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
Template:Oxytocics Script error: No such module "Navbox". Template:Other gynecologicals Template:Prolactin inhibitors and anti-inflammatory products for vaginal administration